The new video for Suave’s #SuaveBeliever campaign features beauty influencers who were sent the fake brand evaus — actually just Suave Professionals — to try for two weeks, and captures their reaction to realizing they had been using Suave the whole time.
“Project Gigaton” will provide an emissions reduction toolkit to a broad network of suppliers seeking to eliminate one gigaton of emissions, focusing on areas such as manufacturing, materials and use of products by 2030.
Through a pilot program from Washington State University College of Pharmacy and with the Idaho Board of Pharmacy’s permission, Albertsons helped bring a pharmacy tech immunization program to its employees.
Medtronic’s patient care, deep vein thrombosis and nutritional insufficiency businesses encompass 23 product categories across multiple market settings, including such brands as Curity, Kendall, Dover, Argyle and Kangaroo.
Through this initiative, Phoenix VA Health Care System nurses will be able to refer veterans to MinuteClinic for the treatment of minor illnesses and injuries through the Veterans Choice Program when clinically appropriate.
It is uncertain if the United States will attempt a similar tactic, but Trump Administration office have repeatedly said they want to lower drug prices by having the Food and Drug Administration approve generic drugs faster.
Good Neighbor Pharmacy and PrescribeWellness are sponsoring the trip, specifically looking for pharmacies that are doing noteworthy things that help them provide better care while also achieving financial success, which will take place in June.
One of the biggest trends in food and beverage in the past several years has been in better-for-you offerings — something that’s expected to continue to influence new products as consumers remain focused on what’s in their favorite snacks and beverages.
Hy-Vee’s recent corporate restructuring will see 70 new corporate hires, roughly 50 of which will be focused on its IT capabilities, the rest of which focus on its Healthmarket format and its restaurants.
The New York Times is reporting that Philadephia-based generics company Lannett continues to raise prices on its drugs, even as the Justice Department is set to launch an anitrust investigations an Connecticut’s attorney general undertakes a drug price investigation into the company. Among the generics that have seen prices increase recently was anti-psychotic fluphenazine, which went from $43.50 to $870 for 100 10-mg capsules in 2016. (New York Times)
A recent survey conducted by ECRM found good alignment between retailers and suppliers, but the findings also suggest that there is room for the relationship to improve. Read ECRM’s SVP retail Wayne Bennett’s takeaways from the survey.